Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Experimental Cell Research
|
July 20, 2002
ROCK-II-induced membrane blebbing and chromatin condensation require actin cytoskeleton
Yuhong Song, Bao Q Hoang, David D Chang
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 5, 2004
Imatinib mesylate (Gleevec) inhibits ovarian cancer cell growth through a mechanism dependent on platelet-derived growth factor receptor alpha and Akt inactivation
Daniela Matei, David D Chang, Meei-Huey Jeng
Molecular Biology of the Cell
|
April 16, 2002
Inhibition of anchorage-independent growth of transformed NIH3T3 cells by epithelial protein lost in neoplasm (EPLIN) requires localization of EPLIN to actin cytoskeleton
Yuhong Song, Raymond S Maul, C Sachi Gerbin, et al.
The Journal of Biological Chemistry
|
December 14, 2001
Molecular basis for interaction between Icap1 alpha PTB domain and beta 1 integrin
David D Chang, Bao Q Hoang, Jenny Liu, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
March 11, 2008
Optimal timing of coronary artery bypass after acute myocardial infarction: a review of California discharge data
Eric S Weiss, David D Chang, David L Joyce, et al.
Oncogene
|
September 6, 2002
Gene expression in epithelial ovarian carcinoma
Daniela Matei, Thomas G Graeber, Rae Lynn Baldwin, et al.
Cancer Research
|
September 18, 2002
Periostin secreted by epithelial ovarian carcinoma is a ligand for alpha(V)beta(3) and alpha(V)beta(5) integrins and promotes cell motility
Lindsay Gillan, Daniela Matei, David A Fishman, et al.
The Journal of Cell Biology
|
February 5, 2003
EPLIN regulates actin dynamics by cross-linking and stabilizing filaments
Raymond S Maul, Yuhong Song, Kurt J Amann, et al.
Molecular Cancer Therapeutics
|
June 15, 2011
Neutralizing monoclonal antibody to periostin inhibits ovarian tumor growth and metastasis
Min Zhu, Romaine E Saxton, Lillian Ramos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 14, 2023
Wild-Type <i>KRAS</i> Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer
Rafael G Amado, Michael Wolf, Marc Peeters, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Experimental Cell Research
|
July 20, 2002
ROCK-II-induced membrane blebbing and chromatin condensation require actin cytoskeleton
Yuhong Song, Bao Q Hoang, David D Chang
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 5, 2004
Imatinib mesylate (Gleevec) inhibits ovarian cancer cell growth through a mechanism dependent on platelet-derived growth factor receptor alpha and Akt inactivation
Daniela Matei, David D Chang, Meei-Huey Jeng
Molecular Biology of the Cell
|
April 16, 2002
Inhibition of anchorage-independent growth of transformed NIH3T3 cells by epithelial protein lost in neoplasm (EPLIN) requires localization of EPLIN to actin cytoskeleton
Yuhong Song, Raymond S Maul, C Sachi Gerbin, et al.
The Journal of Biological Chemistry
|
December 14, 2001
Molecular basis for interaction between Icap1 alpha PTB domain and beta 1 integrin
David D Chang, Bao Q Hoang, Jenny Liu, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
March 11, 2008
Optimal timing of coronary artery bypass after acute myocardial infarction: a review of California discharge data
Eric S Weiss, David D Chang, David L Joyce, et al.
Oncogene
|
September 6, 2002
Gene expression in epithelial ovarian carcinoma
Daniela Matei, Thomas G Graeber, Rae Lynn Baldwin, et al.
Cancer Research
|
September 18, 2002
Periostin secreted by epithelial ovarian carcinoma is a ligand for alpha(V)beta(3) and alpha(V)beta(5) integrins and promotes cell motility
Lindsay Gillan, Daniela Matei, David A Fishman, et al.
The Journal of Cell Biology
|
February 5, 2003
EPLIN regulates actin dynamics by cross-linking and stabilizing filaments
Raymond S Maul, Yuhong Song, Kurt J Amann, et al.
Molecular Cancer Therapeutics
|
June 15, 2011
Neutralizing monoclonal antibody to periostin inhibits ovarian tumor growth and metastasis
Min Zhu, Romaine E Saxton, Lillian Ramos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 14, 2023
Wild-Type <i>KRAS</i> Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer
Rafael G Amado, Michael Wolf, Marc Peeters, et al.
Page
of 2